148 related articles for article (PubMed ID: 7408901)
1. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin.
Maclouf J; Kindahl H; Granström E; Samuelsson B
Eur J Biochem; 1980 Aug; 109(2):561-6. PubMed ID: 7408901
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin.
Maclouf J; Kindahl H; Granström E; Samuelsson B
Adv Prostaglandin Thromboxane Res; 1980; 6():283-6. PubMed ID: 7386268
[No Abstract] [Full Text] [Related]
3. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
Anderson MW; Crutchley DJ; Tainer BE; Eling TE
Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 leads to E2 isomerase.
Raz A; Aharony D
Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):507-15. PubMed ID: 705027
[TBL] [Abstract][Full Text] [Related]
5. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
Fitzpatrick FA; Gorman RR
Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
[TBL] [Abstract][Full Text] [Related]
6. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
Basevich VV; Mevkh AT; Varfolomeev SD
Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
Hornberger WB; Patscheke H
Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles.
Yoshimoto T; Yamamoto S; Hayaishi O
Prostaglandins; 1978 Oct; 16(4):529-40. PubMed ID: 725083
[TBL] [Abstract][Full Text] [Related]
9. A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes.
Diczfalusy U; Hammarström S
FEBS Lett; 1979 Sep; 105(2):291-5. PubMed ID: 488357
[No Abstract] [Full Text] [Related]
10. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
11. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor.
Mais DE; Yoakim C; Guindon Y; Gillard JW; Rokach J; Halushka PV
Biochim Biophys Acta; 1989 Jul; 1012(2):184-90. PubMed ID: 2525928
[TBL] [Abstract][Full Text] [Related]
12. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
[No Abstract] [Full Text] [Related]
13. Increased thromboxane B2 biosynthesis in platelets.
Kawaguchi H; Ishibashi T; Imai Y
Lipids; 1982 Sep; 17(9):577-84. PubMed ID: 6815401
[TBL] [Abstract][Full Text] [Related]
14. The thromboxane antagonist, 13-azaprostanoic acid, inhibits arachidonic acid-induced Ca2+ release from isolated platelet membrane vesicles.
Rybicki JP; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Mar; 751(1):66-73. PubMed ID: 6830832
[TBL] [Abstract][Full Text] [Related]
15. Desensitisation of human platelets against stimulation by thromboxane mimics--reduction in receptor capacity and loss of functional response.
Thierauch KH; Gabriel D; Prior G; Schillinger E
Biomed Biochim Acta; 1988; 47(10-11):S75-8. PubMed ID: 2470362
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma.
Watanabe T; Narumiya S; Shimizu T; Hayaishi O
J Biol Chem; 1982 Dec; 257(24):14847-53. PubMed ID: 6816798
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Biochim Biophys Acta; 1983 Feb; 728(2):171-8. PubMed ID: 6219702
[TBL] [Abstract][Full Text] [Related]
18. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
19. From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.
Samuelsson B
Biosci Rep; 1983 Sep; 3(9):791-813. PubMed ID: 6315101
[No Abstract] [Full Text] [Related]
20. Studies on the thromboxane synthesizing system in human platelet microsomes.
Tai HH; Yuan B
Biochim Biophys Acta; 1978 Dec; 531(3):286-94. PubMed ID: 737191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
